1. Field
The invention generally relates to medical devices inserted into bodily arteries and more particularly to the anchoring of a guidewire guided within a bodily artery at a desired position.
2. Related Art
One known medical procedure is the catheterization process. During the catheterization process, a small incision is made in the skin at an entry site. A vascular tube called a sheath is inserted into the artery or vein allowing for easy catheter exchanges during the catheterization procedures. Guided by medical imaging, such as x-rays or other technology, the catheter is then inserted through the skin and maneuvered through the artery. Once the catheter is in place, contrast media may be injected into the blood vessel and an angiogram is taken of the blocked artery to help identify the site of the blockage. With medical imaging, such as x-rays or other technology, guidance, a thin wire called a guidewire may then be moved to the site to guide the placement of a diagnostic catheter, as well as any additional medical devices such as an angioplasty balloon catheter or a vascular stent, as desired.
There are angioplasty procedures that include the placement of a stent, a small, flexible tube made of plastic or wire mesh to support a damaged blood vessel wall. These stents may be self-expandable or balloon expandable, for example. Once the stent is in place, it may remain in the body permanently, acting as a scaffold for the damaged blood vessel. The guidewire, catheter, and any additional medical devices may then be removed from the patient through the entry site.
Technical difficulties in carotid artery stenting have arisen, particularly in the elderly population, due to arch vessel tortusity and aortic arch elongation and distortion. Stenting in this situation has resulted in adverse events, such as dislodgement of the delivery system from the target vessel during the procedure or failure to catheterize with large-caliber sheaths despite numerous attempts. In extreme cases, tears in the carotid artery and aortic arch can result. Also these excessive unsuccessful manipulations can cause plaque embolization from the aortic arch or carotid origin, and can result in a stroke during the procedure. One approach previously used has been obtaining through-and-through guidewire access using a surgical cutdown of the superficial temporal artery to facilitate the carotid artery stenting in these situations. The through-and-through access improves the ability to stabilize and manipulate the guidewire during the procedure and thus facilitates intervention, which may include carotid stenting, intracranial intervention, or other interventional procedures.
Various anchoring systems have been suggested in the prior art ranging from guidewires with releasable barb anchors to the use of expandable baskets, also referred to as a microwhisk, that may be used for the purpose of anchoring the guidewire. What is needed is an improved micro-anchor that can provide superior anchoring capabilities to the known prior art solutions.
The following summary of the invention is included in order to provide a basic understanding of some aspects and features of the invention. This summary is not an extensive overview of the invention and as such it is not intended to particularly identify key or critical elements of the invention or to delineate the scope of the invention. Its sole purpose is to present some concepts of the invention in a simplified form as a prelude to the more detailed description that is presented below.
According to some embodiments of the invention, an intravascular system is disclosed that includes a guidewire; and a micro-anchor having a figure eight shape connected to the guidewire, the micro-anchor comprising: a first ring connected to the guidewire; and, a second ring connected to at least one of the first ring and the guidewire.
The first ring may be at an angle relative to the second ring. The intravascular system may further include a third ring, wherein the third ring is connected to at least one of the first ring, second ring and the guidewire.
The first ring and the second ring may each comprise a support extending from one end of the ring to an opposite end of the ring. The support of the first ring may be coaxial with the support of the second ring. The support of the first ring and the support of the second ring may be further coaxial with a longitudinal axis of the guidewire.
The micro-anchor may be capable of accepting a pin, the pin guidable through at least one of the first ring and the second ring to secure the guidewire within an artery.
The guidewire may include a tip, wherein the tip of the guidewire is angled to facilitate selection of an external carotid artery and navigate the guidewire therein. The micro-anchor may be attached to a tip of the guidewire.
The micro-anchor may be moveable between a collapsed first position and an expanded second position. The intravascular system may further include a sheath, the guidewire and the micro-anchor guideable through the sheath. The micro-anchor may be in the collapsed first position while the micro-anchor is within the sheath. The micro-anchor is in the expanded second position while the micro-anchor is outside the sheath.
According to other embodiments of the invention, an intravascular system is disclosed that includes a guidewire; and a micro-anchor connected to the guidewire, the micro-anchor comprising: a plurality of petals connected to the guidewire; and, a ring connected to each of the plurality of petals.
The micro-anchor may be capable of accepting a pin, the pin guidable through at least one of the plurality of petals to secure the guidewire within an artery.
The guidewire may extend through the micro-anchor.
The micro-anchor may be moveable between a collapsed first position and an expanded second position. The intravascular system may further include a sheath, the guidewire and the micro-anchor guideable through the sheath. The micro-anchor may be in the collapsed first position while the micro-anchor is within the sheath. The micro-anchor may be in the expanded second position while the micro-anchor is outside the sheath.
The accompanying drawings, which are incorporated into and constitute a part of this specification, illustrate one or more examples of embodiments and, together with the description of example embodiments, serve to explain the principles and implementations of the embodiments.
A steerable intravascular anchor is disclosed that comprises an anchor portion and is steerable to a position in a superficial temporal artery. The anchor can then be pinned thereto by an external device protruding through the superficial temporal artery by advancing a pin through the skin. The pin is steered through the skin into the anchor under, for example, fluoroscopic guidance. The anchor portion, in one embodiment, may have a figure-eight shape. The anchor portion may include two wires, each wire forming a ring. The rings may be located on the same plane or at an angle relative to one another. In another embodiment, the anchor portion includes a plurality of wires each wire formed in a ring, and each ring being connected to at least one other ring. It will be appreciated that the wires may be formed into other shapes, such as loops, triangles, squares, pentagons, hexagons, and the like, and combinations thereof.
The guidewire 112 may be composed of stainless steel which may be monofilament or braided. The guidewire 112 and the micro-anchor 116 may instead be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, or a nickel-titanium, and may be created by alloying zinc, copper, gold and iron. Additionally, the guidewire may be coated in Teflon, polyurethane, or another lubricious polymer.
During one exemplary catheterization process, a small incision is made in the skin at an entry site opening to a blood vessel, for example, the femoral artery. The catheter apparatus component 110, including the guidewire sheath 114 and its enclosed guidewire 112 and micro-anchor 116 (in its collapsed position within the guidewire sheath 114), may then be guided into the blood vessel. The catheter apparatus component 110 is flexible enough to travel through a tortuous path. During the feeding process, a user typically observes the travel of the catheter apparatus component 110 by x-ray or other technology as the catheter travels through the blood vessel. During the feeding process, the micro-anchor 116 remains inside of the guidewire sheath 114. The catheter apparatus component 110 is fed and guided until it reaches, for example, the superficial temporal artery in the side of a patient's face, or other appropriate artery. The guidewire 112 may then be forced out of an end of the guidewire sheath 114, causing the micro-anchor 116 to exit the guidewire sheath 114 and to deploy. As it is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchor 116 will then deploy to its original shape (i.e., expanded shape) within the superficial temporal artery, or other appropriate artery.
The micro-anchor 116 may be accessible regardless of the rotation of the micro-anchor 116 within the artery or other vessel. The size of the micro-anchor is selected for the artery or vessel. For example, for a superficial temporal artery, the diameter of the deployed or expanded micro-anchor may be any value or range of values between about 1.5 mm to 5 mm. It will be appreciated that the diameter may be less than 1.5 mm or more than 5 mm.
The medical device 100 also has an anchoring device 120 component. The device may include a pin portion 122 and a handle portion 124. Further, the handle portion may take on various forms, such as, but not limited to, the embodiment shown in
The pin portion 122 is inserted substantially perpendicularly to the artery or other vessel in which the micro-anchor is deployed. The pin portion 122 is guided to and through the micro-anchor 116 to stabilize the micro-anchor 116, and, therefore the guidewire 112. The stabilization of the guidewire 112 increases the ease of subsequent medical treatments, such as angioplasty and stenting processes.
Embodiments of the invention are directed to a micro-anchor 116 that ensures better anchoring over prior art solutions. In particular, the micro-anchor 116 is designed and configured to receive the pin portion 122 of the anchoring device 120. The micro-anchor 116 described herein may provide greater control over the manipulation and positioning of a guidewire for the placement of medical devices.
In the embodiment shown in
In some embodiments, the first ring 200 is oriented at a different angle than the second ring 204. For example, the second ring 204 may be positioned at a 90 degree relative to the first ring 200. It will be appreciated that the angle may be less than or more than 90 degrees. By orienting the rings 200, 204 at different angles, it is more likely that the pin portion 122 of the anchoring device 120 will engage with either ring 200 or ring 204.
While the micro-anchor is shown in
Furthermore, while the rings are shown to be in the shape of a circle, one of ordinary skill in the art will appreciate that other shapes may be used including, without limitation, ellipses and polygons (not shown).
The micro-anchor 116A is connected to the guidewire 112 by connecting either or both the first ring 200 or the second ring 204 to the guidewire 112. The first ring 200 and second ring 204 are co-axial with one another and with the guidewire 112. In the embodiment shown in
In one embodiment, as shown in
In one embodiment, as shown in
As noted above, the guidewire 112 may be composed of stainless steel which may be monofilament or braided. The guidewire 112 and the micro-anchor 116A may instead be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, or a nickel-titanium, and may be created by alloying zinc, copper, gold and iron. Additionally, the guidewire 112 may be coated in Teflon, polyurethane, or another lubricious polymer. As it is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchor 116A will then deploy to its expanded shape within the superficial temporal artery, or other appropriate artery.
It will be appreciated that the micro-anchor 116A having the figure eight shape may be formed by molding the micro-anchor 116A out of a malleable material to have a shape similar to that shown in
In use, the micro-anchor 116A is delivered to a patient site as described above in a first, collapsed shape. At the patient site, the micro-anchor 116A is deployed and expanded into its second, expanded shape, shown in
The micro-anchor 116B itself comprises a plurality of rings connect to one another. As shown in detail in
Ring 310 is connected to ring 320 at connection point 319, ring 320 is connected to ring 330 at connection point 329, and ring 330 is connected to ring 310 at connection point 339. The connection may be done by pressing, soldering, welding or the like. Alternatively, the micro-anchor 116B may be formed by etching a wire.
While in
The guidewire 112 is split into a proximal portion and a distal portion. The guidewire 112 is further split at the proximal end of the distal portion to form first guidewire portion 340 and second guidewire portion 342. First guidewire portion 340 is connected to micro-anchor 116B at connection point 344. Second guidewire portion 342 is connected to micro-anchor 116B at connection point 346. It will be appreciated that connections may occur at other places on the micro-anchor 116B than those shown in
The rings 310, 320, 330 are positioned such that when the micro-anchor 116B is expanded, the rings 320, 320, 330 together form the outer surface of the micro-anchor 116B. As shown in
The micro-anchor 116B is connected to a guidewire 112 on both ends of the micro-anchor 116B. In one embodiment the guidewire 112 has a short angulated tip 113, the tip 113 being positioned outside the maximum scope of the deployed micro-anchor 116B.
The micro-anchor 116B may instead be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, nickel-titanium or the like, and may be created by alloying, for example, zinc, copper, gold, iron, and the like. As the micro-anchor 116B is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchor 116B will then deploy to its original shape within the superficial temporal artery, or other appropriate artery.
In use, the micro-anchor 116B is delivered to a patient site as described above in a first, collapsed shape. At the patient site, the micro-anchor 116B is deployed and expanded into its second, expanded shape, shown in
As shown in
While two rings 410 and 420 are shown, one of ordinary skill in the art would readily appreciate that any number of rings may be used without departing from the scope of the invention. Moreover, while elements 410 and 420 are shown as circles, one of ordinary skill in the art would readily appreciate that other shapes may be used, including without limitations ellipses and polygons.
The micro-anchor 116C may instead be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, nickel-titanium or the like, and may be created by alloying, for example, zinc, copper, gold, iron, and the like.
In use, the micro-anchor 116C is delivered to a patient site as described above in a first, collapsed shape. At the patient site, the micro-anchor 116C is deployed and expanded into its second, expanded shape, shown in
Reference is now made to
The petals may be formed by forming a wire into the shape of the petal and connecting them to the end of the guidewire using known methods. Alternatively, the petals may be formed by etching the end of the guidewire 112 to have the shape shown in
In
Similarly, as shown in
Likewise, as shown in
One of ordinary skill in the art will readily appreciate that the combinations shown in
The micro-anchors 500, 600 and 700 are positioned at the end of the guidewire 112 (i.e., the micro-anchor 500, 600 or 700 is the tip of the guidewire 112). The operation of the micro-anchors 500, 600 or 700 is similar to the operation discussed herein in that it is while within the sheath 114 is compressed to fit therein, and, when pushed outside of the sheath 114, it resumes its open position, and may be used for anchoring purposes as described herein. The collapsed positions of the micro-anchors 500, 600, and 700 are shown in
The micro-anchors 500, 600 or 700 may be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, or a nickel-titanium, and may be created by alloying zinc, copper, gold and iron. As it is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchors 500, 600 or 700 will then deploy to their original shape within the superficial temporal artery, or other appropriate artery.
In an alternative embodiment to that shown in
In use, the micro-anchor 500, 600 or 700 are delivered to a patient site as described above in a first, collapsed shape (500B, 600B or 700B as the case may be). At the patient site, the micro-anchor 500, 600 or 700 is deployed and expanded into its second, expanded shape, shown in
Reference is now made to
As shown in
The micro-anchor 800 may be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, or a nickel-titanium, and may be created by alloying zinc, copper, gold and iron. As it is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchors 800 will then deploy to their original shape within the superficial temporal artery, or other appropriate artery.
In use, the micro-anchor 800 is delivered to a patient site as described above in a first, collapsed shape (not shown). At the patient site, the micro-anchor 800 is deployed and expanded into its second, expanded shape, shown in
In
The micro-anchor 900 may be composed of a shape-memory alloy, such as nitinol. Alternatively, the shape-memory alloy may be a copper-aluminum-nickel, or a nickel-titanium, and may be created by alloying zinc, copper, gold and iron. As it is made from a shape memory alloy exhibiting a temperature response at approximately body temperature, the micro-anchors 900 will then deploy to their original shape within the superficial temporal artery, or other appropriate artery. However, one of ordinary skill in the art would readily appreciate that other metals and/or alloys may be used, including but not limited to non-shape memory alloy.
In another exemplary process of deployment, the presently disclosed system may be used to access and navigate a type III aortic arch. A first catheter, such as a Simmons catheter or other catheter having a reverse curve or hook configuration, may be used to gain access to the ascending aorta and carotid artery and to secure the catheter in place. A micro catheter or guidewire sheath may then be advanced through the first catheter and advanced into the carotid artery. In one embodiment, a guidewire having a micro-anchor of any one of the types disclosed herein, is disposed within the micro catheter. The micro-anchor has a tip that may be angled to facilitate selection of the external carotid artery and navigate the micro catheter to the desired location. This would allow anchoring the system to enable accurate and undisturbed access to the internal carotid artery, thereby facilitating the stenting procedure therein. One of ordinary skill in the art would readily appreciate that the system can be similarly used in cases of other arteries where the securing of such or a similar system is necessary, without departing from the scope of the invention. Upon reaching the desired location, the micro-anchor may be extended from the micro catheter allowing the micro-anchor to expand and be secured in the vessel with an anchoring device as discussed below. In another embodiment, a conventional guidewire may be used to advance the micro catheter to the desired location. Upon reaching the desired location, the conventional guidewire may be removed, and the guidewire having micro-anchor may be inserted and advanced through the catheter until the micro-anchor extends from the micro catheter and expands to be secured in the vessel. Once the micro-anchor is secured, a carotid stenting or other procedure may be performed. In this manner the system may provide a stabilized platform for intervention in tortuous arteries of the head, neck or other extremities.
The intravascular anchor described herein facilitates the stenting of the internal carotid artery or common carotid artery. However, this should not be viewed as limiting the scope of the invention. For instance, and without limitations, the disclosed inventions as well as embodiments thereof, may apply to the stenting of the subclavian artery by anchoring in the radial artery. It may be further used, without limitation, for stenting in the lower extremity in situations of acute angulation or tortuosity at the aorto iliac bifurcation. In this case, a practitioner could access the common femoral artery using a retrograde contralateral approach and intervene in the opposite lower extremity by anchoring a device implemented according to the principles of the invention anywhere in the lower extremity.
While the invention has been described in terms of several embodiments, those of ordinary skill in the art will recognize that the invention is not limited to the embodiments described, but can be practiced with modification and alteration within the spirit and scope of the appended claims. The description is thus to be regarded as illustrative instead of limiting. There are numerous other variations to different aspects of the invention described above, which in the interest of conciseness have not been provided in detail. Accordingly, other embodiments are within the scope of the claims.
The invention has been described in relation to particular examples, which are intended in all respects to be illustrative rather than restrictive. Those skilled in the art will appreciate that many different combinations will be suitable for practicing the present invention. Other implementations of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. Various aspects and/or components of the described embodiments may be used singly or in any combination. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
This patent application is a continuation-in part application and claims priority to PCT Application No. PCT/US2013/071271, entitled “System for the Intravascular Placement of a Medical Device”, and having an international filing date of Nov. 21, 2013, which claims priority to U.S. Provisional Application No. 61/728,862, filed Nov. 21, 2012, both assigned to common assignee, the disclosures of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4243040 | Beecher | Jan 1981 | A |
4790331 | Okada et al. | Dec 1988 | A |
5098707 | Baldwin et al. | Mar 1992 | A |
5293772 | Carr, Jr. | Sep 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5419777 | Hofling | May 1995 | A |
5571135 | Fraser et al. | Nov 1996 | A |
5651366 | Liang et al. | Jul 1997 | A |
5662703 | Yurek et al. | Sep 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5718702 | Edwards | Feb 1998 | A |
5720735 | Dorros | Feb 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5807330 | Teitelbaum | Sep 1998 | A |
5813976 | Filipi | Sep 1998 | A |
5957901 | Mottola et al. | Sep 1999 | A |
5997563 | Kretzers | Dec 1999 | A |
6027462 | Greene et al. | Feb 2000 | A |
6059813 | Vrba et al. | May 2000 | A |
6070589 | Keith et al. | Jun 2000 | A |
6152141 | Stevens et al. | Nov 2000 | A |
6238410 | Vrba et al. | May 2001 | B1 |
6245017 | Hashimoto | Jun 2001 | B1 |
6245573 | Spillert | Jun 2001 | B1 |
6428567 | Wilson et al. | Aug 2002 | B2 |
6450964 | Webler | Sep 2002 | B1 |
6464665 | Heuser | Oct 2002 | B1 |
6494875 | Mauch | Dec 2002 | B1 |
6544278 | Vrba et al. | Apr 2003 | B1 |
6663613 | Lewis et al. | Dec 2003 | B1 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6780174 | Mauch | Aug 2004 | B2 |
6808520 | Fouirkas et al. | Oct 2004 | B1 |
6837881 | Barbut | Jan 2005 | B1 |
6929633 | Evans et al. | Aug 2005 | B2 |
6932829 | Majercak | Aug 2005 | B2 |
6942682 | Vrba et al. | Sep 2005 | B2 |
7235083 | Perez et al. | Jun 2007 | B1 |
7393358 | Malewicz | Jul 2008 | B2 |
7651520 | Fischell et al. | Jan 2010 | B2 |
7674493 | Hossainy et al. | Mar 2010 | B2 |
7740791 | Kleine et al. | Jun 2010 | B2 |
7758624 | Dorn et al. | Jul 2010 | B2 |
7763010 | Evans et al. | Jul 2010 | B2 |
7766961 | Patel et al. | Aug 2010 | B2 |
7828832 | Belluche et al. | Nov 2010 | B2 |
7842026 | Cahill et al. | Nov 2010 | B2 |
7955370 | Gunderson | Jun 2011 | B2 |
8092509 | Dorn et al. | Jan 2012 | B2 |
8119184 | Hossainy et al. | Feb 2012 | B2 |
8202309 | Styrc | Jun 2012 | B2 |
8241241 | Evans et al. | Aug 2012 | B2 |
8343181 | Duffy et al. | Jan 2013 | B2 |
8419767 | Al-Qbandi et al. | Apr 2013 | B2 |
8535290 | Evans et al. | Sep 2013 | B2 |
8721714 | Kelley | May 2014 | B2 |
8727988 | Flaherty et al. | May 2014 | B2 |
8728144 | Fearnot | May 2014 | B2 |
8740971 | Iannelli | Jun 2014 | B2 |
8986241 | Evans et al. | Mar 2015 | B2 |
8998894 | Mauch et al. | Apr 2015 | B2 |
9301830 | Heuser et al. | Apr 2016 | B2 |
9314499 | Wang et al. | Apr 2016 | B2 |
9636244 | Syed | May 2017 | B2 |
9855705 | Wang et al. | Jan 2018 | B2 |
9980838 | Syed | May 2018 | B2 |
20010003985 | Lafontaine et al. | Jun 2001 | A1 |
20010049534 | Lachat | Dec 2001 | A1 |
20020077691 | Nachtigall | Jun 2002 | A1 |
20020123698 | Garibotto et al. | Sep 2002 | A1 |
20020156518 | Tehrani | Oct 2002 | A1 |
20020165535 | Lesh | Nov 2002 | A1 |
20030088187 | Saadat et al. | May 2003 | A1 |
20030216721 | Diederich | Nov 2003 | A1 |
20030229282 | Burdette | Dec 2003 | A1 |
20040073190 | Deem et al. | Apr 2004 | A1 |
20040087995 | Copa et al. | May 2004 | A1 |
20040138734 | Chobotov et al. | Jul 2004 | A1 |
20040147837 | Macaulay et al. | Jul 2004 | A1 |
20040167463 | Zawacki et al. | Aug 2004 | A1 |
20050043779 | Wilson | Feb 2005 | A1 |
20050085841 | Eversull et al. | Apr 2005 | A1 |
20050101968 | Dadourian | May 2005 | A1 |
20050113862 | Besselink et al. | May 2005 | A1 |
20050222488 | Chang et al. | Oct 2005 | A1 |
20050234499 | Olson et al. | Oct 2005 | A1 |
20050251160 | Saadat et al. | Nov 2005 | A1 |
20060025752 | Broaddus et al. | Feb 2006 | A1 |
20060025844 | Majercak et al. | Feb 2006 | A1 |
20060030923 | Gunderson | Feb 2006 | A1 |
20060036218 | Goodson et al. | Feb 2006 | A1 |
20060155363 | Laduca et al. | Jul 2006 | A1 |
20060200221 | Malewicz | Sep 2006 | A1 |
20060257389 | Binford | Nov 2006 | A1 |
20060259063 | Bates | Nov 2006 | A1 |
20060270900 | Chin et al. | Nov 2006 | A1 |
20070016019 | Salgo | Jan 2007 | A1 |
20070016062 | Park | Jan 2007 | A1 |
20070038061 | Huennekens et al. | Feb 2007 | A1 |
20070038293 | St Goar et al. | Feb 2007 | A1 |
20070049867 | Shindelman | Mar 2007 | A1 |
20070083215 | Hamer et al. | Apr 2007 | A1 |
20070118151 | Davidson et al. | May 2007 | A1 |
20070129719 | Kendale et al. | Jun 2007 | A1 |
20080039746 | Hissong et al. | Feb 2008 | A1 |
20080114239 | Randall et al. | May 2008 | A1 |
20080194993 | McLaren | Aug 2008 | A1 |
20080208309 | Saeed | Aug 2008 | A1 |
20080281398 | Koss | Nov 2008 | A1 |
20090005679 | Dala-Krishna | Jan 2009 | A1 |
20090018526 | Power | Jan 2009 | A1 |
20090036780 | Abraham | Feb 2009 | A1 |
20090093791 | Heuser | Apr 2009 | A1 |
20090132019 | Duffy et al. | May 2009 | A1 |
20090171293 | Yang et al. | Jul 2009 | A1 |
20090177035 | Chin | Jul 2009 | A1 |
20090240253 | Murray | Sep 2009 | A1 |
20090254116 | Rosenschein et al. | Oct 2009 | A1 |
20090270975 | Giofford, III et al. | Oct 2009 | A1 |
20090319017 | Berez et al. | Dec 2009 | A1 |
20100016943 | Chobotov | Jan 2010 | A1 |
20100024818 | Stenzler et al. | Feb 2010 | A1 |
20100030165 | Takagi et al. | Feb 2010 | A1 |
20100030256 | Dubrul et al. | Feb 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100168583 | Dausch et al. | Jul 2010 | A1 |
20100185161 | Pellegrino et al. | Jul 2010 | A1 |
20100185231 | Lashinski | Jul 2010 | A1 |
20100204708 | Sharma | Aug 2010 | A1 |
20100268067 | Razzaque et al. | Oct 2010 | A1 |
20100272740 | Vertegel et al. | Oct 2010 | A1 |
20100298922 | Thornton et al. | Nov 2010 | A1 |
20110009943 | Paul et al. | Jan 2011 | A1 |
20110034987 | Kennedy | Feb 2011 | A1 |
20110071394 | Fedinec | Mar 2011 | A1 |
20110082533 | Vardi et al. | Apr 2011 | A1 |
20110213459 | Garrison | Sep 2011 | A1 |
20110224773 | Gifford et al. | Sep 2011 | A1 |
20110230830 | Gifford, III et al. | Sep 2011 | A1 |
20110270375 | Hartley et al. | Nov 2011 | A1 |
20120016343 | Gill | Jan 2012 | A1 |
20120022636 | Chobotov | Jan 2012 | A1 |
20120029478 | Kurosawa | Feb 2012 | A1 |
20120034205 | Alkon | Feb 2012 | A1 |
20120035590 | Whiting et al. | Feb 2012 | A1 |
20120169712 | Hill et al. | Jul 2012 | A1 |
20120020942 | Hall et al. | Aug 2012 | A1 |
20120209375 | Madrid et al. | Aug 2012 | A1 |
20120289945 | Segermark | Nov 2012 | A1 |
20130053792 | Fischell et al. | Feb 2013 | A1 |
20130131777 | Hartley et al. | May 2013 | A1 |
20130296773 | Feng et al. | Nov 2013 | A1 |
20130331819 | Rosenman et al. | Dec 2013 | A1 |
20130331921 | Roubin | Dec 2013 | A1 |
20140031925 | Garrison et al. | Jan 2014 | A1 |
20140142427 | Petroff | May 2014 | A1 |
20140214002 | Thermopeutix | Jul 2014 | A1 |
20140228808 | Webster et al. | Aug 2014 | A1 |
20140358123 | Ueda et al. | Dec 2014 | A1 |
20150018942 | Hung et al. | Jan 2015 | A1 |
20150190576 | Lee et al. | Jul 2015 | A1 |
20150201900 | Syed | Jul 2015 | A1 |
20150245933 | Syed | Sep 2015 | A1 |
20150250991 | Silvestro | Sep 2015 | A1 |
20150352331 | Helm, Jr. | Dec 2015 | A1 |
20150366536 | Courtney et al. | Dec 2015 | A1 |
20150374261 | Grunwald | Dec 2015 | A1 |
20160008058 | Hu et al. | Jan 2016 | A1 |
20160038724 | Madsen et al. | Feb 2016 | A1 |
20160120509 | Syed | May 2016 | A1 |
20160120673 | Siegel et al. | May 2016 | A1 |
20160296355 | Syed | Oct 2016 | A1 |
20160338835 | Bioventrix | Nov 2016 | A1 |
20170119562 | Syed | May 2017 | A1 |
20170119563 | Syed | May 2017 | A1 |
20170135833 | Syed | May 2017 | A1 |
20170181876 | Syed | Jun 2017 | A1 |
20170304095 | Syed | Oct 2017 | A1 |
20170361062 | Syed | Dec 2017 | A1 |
20180042743 | Syed | Feb 2018 | A1 |
20180059124 | Syed | Mar 2018 | A1 |
20180116780 | Laine | May 2018 | A1 |
20180250147 | Syed | Sep 2018 | A1 |
20190091441 | Syed | Mar 2019 | A1 |
20190254675 | Syed | Aug 2019 | A1 |
20190255286 | Syed | Aug 2019 | A1 |
20190336114 | Syed | Nov 2019 | A1 |
Number | Date | Country |
---|---|---|
108472124 | Aug 2018 | CN |
108472472 | Aug 2018 | CN |
108882975 | Nov 2018 | CN |
109475722 | Mar 2019 | CN |
3280355 | Feb 2018 | EP |
3367969 | Sep 2018 | EP |
3368123 | Sep 2018 | EP |
3399944 | Nov 2018 | EP |
3405261 | Nov 2018 | EP |
201827018555 | Oct 2018 | IN |
201827018768 | Oct 2018 | IN |
1996036269 | Nov 1996 | WO |
2004089249 | Oct 2004 | WO |
2011011539 | Jan 2011 | WO |
WO2011106502 | Sep 2011 | WO |
2010129193 | Nov 2011 | WO |
2011137336 | Nov 2011 | WO |
2012030101 | Aug 2012 | WO |
2014081947 | May 2014 | WO |
2014197839 | Dec 2014 | WO |
2016164215 | Oct 2016 | WO |
2017074492 | May 2017 | WO |
2017074536 | May 2017 | WO |
2017127127 | Jul 2017 | WO |
2017222571 | Dec 2017 | WO |
2017222612 | Dec 2017 | WO |
2018164766 | Sep 2018 | WO |
2019070349 | Apr 2019 | WO |
2019160625 | Aug 2019 | WO |
2019160626 | Aug 2019 | WO |
Entry |
---|
Godwin, J., The Circulatory and Respiratory Systems, Z0250 Lab III, 2002, retrieved from: https://projects.ncsu.edu/cals/course/zo250/1ab-3.html. |
Stroke Treatments, American Heart Association, Retrieved from: Http://www.strokeassociation.org/STROKEORG/ AboutStroke/Treatment/Stroke-Treatments_UCM_310892_Article.jsp#V9Hrg2WfV_1. |
Beckman et al., Venous Thromboembolism: A Public Health Concern, Am J Prev Med., 2010, vol. 38(4), pp. S495-S501. |
Meunier et al., Individual Lytic Efficacy of Recombinant Tissue Plasminogen Activator in an in-vitro Human Clot Model: Rate of Nonresponse Acad Emerg Med., 2013, vol. 20(5), pp. 449-455. |
Tripathi et al., Use of Tissue Plasminogen Activator for Rapoid Dissolution of Fibrin and Blood Clots in the Eye After Surgery for Claucomoa and Cataract in Humans, Drug Development Research, 1992, vol. 27(2), pp. 147-159. |
International Search Report and Written Opinion for International Application No. PCT/US2016/024795 dated Aug. 30, 2016, 14 pages. |
International Search Report and Written Opinion issued for International Application No. PCT/US2016/024794 dated Jul. 1, 2016, 10 pages. |
International Search Report and Written Opinion issued for International Application No. PCT/US2016/047163 dated Oct. 28, 2016, 9 pages. |
International Search Report and Written Opinion issued for International Application No. PCT/US2017/021188 dated May 10, 2017, 11 pages. |
International Preliminary Report on Patentability issued in International Application No. PCT/US2013/071271 dated May 26, 2015, 6 pages. |
Office Action issued in U.S. Appl. No. 13/750,920 dated Apr. 8, 2015. |
Response to Office Action in U.S. Appl. No. 13/750,920 dated Aug. 10, 2015. |
Supplemental Response to Office Action in U.S. Appl. No. 13/750,920 dated Nov. 2, 2015. |
Office Action in U.S. Appl. No. 13/750,920 dated Nov. 5, 2015. |
Response to Office Action in U.S. Appl. No. 13/750,920 dated Feb. 11, 2016. |
International Search Report and Written Opinion issued for International Application No. PCT/US2016/047165 dated Jan. 5, 2017, 13 pages. |
International Search Report for PCT/US2013/071271 dated Feb. 10, 2014. |
International Preliminary Report on Patentability issued in International Application No. PCT/US2016/024795 dated May 1, 2018, 10 pages. |
International Preliminary Report on Patentability issued in International Application No. PCT/US2016/047165 dated May 1, 2018, 5 pages. |
International Search Report and Written Opinion issued for PCT/US2018/012834 dated Mar. 15, 2018,13 pages. |
Schwartz et al., Intracardiac Echocardiography in Humans using a Small-Sized (6F), Low Frequency (125 MHz) Ultrasound Catheter Methods, Imaging Planes and Clinical Experience, Journal of the American College of Cardiology, 1993, vol. 21(1), pp. 189-198. |
Blaney et al., Alteplase for the Treatment of Central Venous Catheter Occlusion in Children: Results of a Prospective, Open-Label, Single-Arm Study (The Cathflo Activase Pediatric Study), J Vase Interv Radiol, 2006, vol. 17 (11), pp. 1745-1751. |
Shah, T., Radiopaque Polymer Formulations for Medical Devices, MDDI Medical Diagnostic and Device Industry: Materials, 2001, retrieved from: https://www.mddionline.com/radiopaque-polymer-formulations-medical-devices. |
International Preliminary Report on Patentability issued for PCT/US2016/047163 dated Dec. 25, 2018, 7 pages. |
International Preliminary Report on Patentability issued for PCT/US2017/021188 dated Dec. 25, 2018, 9 pages. |
International Search Report and Written Opinion for PCT/US2018/047372 dated Jan. 2, 2019, 8 pages. |
International Search Report and Written Opinion for PCT/US2019/012727 dated Mar. 21, 2019, 12 pages. |
International Search Report and Written Opinion for PCT/US2019/12745 dated Apr. 1, 2019, 10 pages. |
EP 16777055.1 Extended Search Report dated Feb. 12, 2019, 7 pages. |
EP 18725097.2 Extended Search Report dated Apr. 24, 2019, 9 pages. |
EP 16860437.9 Extended Search Report dated May 17, 2019. |
EP 16860409.8 Extended Search Report dated Jun. 27, 2019. |
Number | Date | Country | |
---|---|---|---|
20150174377 A1 | Jun 2015 | US |
Number | Date | Country | |
---|---|---|---|
61728862 | Nov 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US2013/071271 | Nov 2013 | US |
Child | 14638438 | US |